INVESTOR RELATIONS

Please Contact David Schull for further information

David Schull
Russo Partners
212.845.4271
david.schull@russopartnersllc.com

January 08, 2008
Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure

December 20, 2007
Corthera Closes $23 Million Financing Round